Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-22 4:33 pm Purchase |
2024-05-14 | 13G | MiNK Therapeutics, Inc. INKT |
GKCC LLC | 464,000 11.790% |
464,000 (New Position) |
Filing History |
| 2024-02-14 6:05 pm Purchase |
2024-01-16 | 13D | MiNK Therapeutics, Inc. INKT |
ARMEN GARO H | 351,432 9.680% |
89,744 (+34.29%) |
Filing History |
| 2023-05-26 5:03 pm Purchase |
2023-05-19 | 13D | IMARA Inc. IMRA |
ANTIGENICS INC AGEN |
21,522,157 62.500% |
177,472 (+0.83%) |
Filing History |
| 2023-05-03 5:23 pm Purchase |
2023-05-01 | 13D | IMARA Inc. IMRA |
ANTIGENICS INC AGEN |
21,344,685 62.000% |
14,761,446 (+224.23%) |
Filing History |
| 2022-02-14 4:06 pm Purchase |
2021-12-31 | 13G | MiNK Therapeutics, Inc. INKT |
ARMEN GARO H | 261,688 7.820% |
261,688 (New Position) |
Filing History |
| 2021-10-28 4:30 pm Purchase |
2021-10-19 | 13D | IMARA Inc. IMRA |
ANTIGENICS INC AGEN |
6,583,240 79.800% |
6,583,240 (New Position) |
Filing History |